How should Nephrosteril (amino acid parenteral nutrition solution) be administered to adult patients, including dilution, dosing, infusion rate, and monitoring?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

How to Administer Nephrosteril

Nephrosteril, as an amino acid parenteral nutrition solution, should be administered intravenously as part of a complete parenteral nutrition regimen, typically combined with glucose and lipid emulsions in an all-in-one formulation, with dosing of 1.2-1.5 g amino acids/kg/day for most adult patients.

Preparation and Dilution

Nephrosteril is a crystalline amino acid solution that must be combined with other parenteral nutrition components before administration 1. The solution should:

  • Never be administered alone - it must be mixed with glucose solutions, lipid emulsions, and appropriate electrolytes, vitamins, and trace elements 1
  • Be prepared using aseptic technique in a suitable environment (typically hospital pharmacy)
  • Be stored under refrigeration at 2-8°C prior to use
  • Be gently warmed to room temperature before infusion 1

Dosing Guidelines

Standard Adult Dosing

For adults with normal metabolism:

  • Start with 0.8 g amino acids/kg/day as baseline
  • Increase to 1.2-1.5 g/kg/day for most hospitalized patients 2
  • May increase up to 2.0-2.5 g/kg/day in exceptional cases of severe catabolism 2

Special Populations

Critically ill patients:

  • Target 1.2-1.5 g amino acids/kg/day (equivalent to 0.2-0.24 g nitrogen/kg/day) 3
  • Consider glutamine supplementation at 0.3-0.4 g glutamine dipeptide/kg/day if indicated 3, 2

Patients with acute kidney injury on continuous renal replacement therapy:

  • Higher doses up to 2.5 g/kg/day may be required to account for amino acid losses across the hemofilter (approximately 17% of infused amino acids are lost in dialysate) 4, 5
  • This higher intake optimizes nitrogen balance and corrects amino acid deficiencies 5

Patients with chronic kidney disease:

  • Reduce to 0.14-0.2 g nitrogen/kg/day (approximately 0.9-1.25 g amino acids/kg/day) if hepatic or renal failure complicates the clinical picture 3

Energy Balance

Critical consideration: Amino acids must be infused with adequate non-protein energy sources to ensure proper utilization 2:

  • Maintain a nitrogen:calorie ratio of 1:130 to 1:170 (g N/kcal) or 1:21 to 1:27 (g amino acids/kcal) under normal metabolic conditions 2
  • Provide 25-30 kcal/kg/day for well-nourished patients 6, 3
  • Reduce to 15-20 kcal/kg/day in patients with SIRS, MODS, or refeeding syndrome risk 3

Infusion Rate and Timing

For peripheral or central venous administration:

  • Infuse continuously over 24 hours, or
  • Use cyclical infusion over 10-12 hours (typically overnight for home PN) 7
  • When starting cyclical PN, increase non-protein energy progressively over 90 minutes, then start amino acid infusion at constant rate 7
  • Plasma amino acid concentrations reach steady-state within 3-6 hours of infusion 7

Early initiation is critical:

  • Begin within 24-48 hours of admission after hemodynamic stabilization 3, 8
  • In critically ill patients, start enteral nutrition within 48 hours if gut is functional; if contraindicated, implement PN within 3-7 days 8

Monitoring Requirements

Baseline Assessment

  • Serum electrolytes (sodium, potassium, chloride, bicarbonate)
  • Renal function (creatinine, BUN)
  • Liver function tests
  • Acid-base status 6

Ongoing Monitoring

  • Daily: Fluid balance, urine output (target ≥0.8-1 L/day), clinical signs of dehydration 6
  • Weekly to monthly: Electrolytes, renal and liver function, trace elements, vitamins 6
  • Nitrogen balance: Monitor urea excretion to tailor actual nitrogen needs 3
  • 24-hour urine output: To assess adequacy of PN volume 6

Common Pitfalls to Avoid

  1. Overfeeding: Do not exceed 30 kcal/kg/day in most patients; limit to 15-20 kcal/kg/day in SIRS/MODS 3

  2. Inadequate protein with excessive calories: This is particularly problematic in critically ill patients who need generous protein but not toxic energy loads 9

  3. Ignoring losses in renal replacement therapy: Patients on CRRT lose significant amino acids (17%) and glucose (4%) in dialysate - increase doses accordingly 5

  4. Administering water for injection alone: Never infuse water for injection independently due to low osmolarity 1

  5. Peripheral administration of hypertonic solutions: Glucose concentrations >12.5% w/v should be given centrally to avoid complications 1

  6. Inadequate amino acid profile: For long-term PN, ensure BCAA content includes at least 0.10 g/kg leucine, 0.08 g/kg isoleucine, and 0.06 g/kg methionine to maintain skeletal muscle mass 10

References

2
Research

Amino acids - Guidelines on Parenteral Nutrition, Chapter 4.

German medical science : GMS e-journal, 2009

Related Questions

How should an amino‑acid infusion be administered and dosed in total parenteral nutrition?
How do Aminoven (10% amino‑acid solution) and Aminoplasmal (8% amino‑acid solution) compare regarding composition, electrolyte content, and suitability for adult parenteral nutrition?
What are the recommended starting doses and titration guidelines for amino acid administration in adults, including adjustments for critical illness, renal disease, and hepatic insufficiency?
How should Nephrosteril (amino acid solution) be administered via a secondary (side‑drip) IV line for an adult patient (≈70 kg) requiring 0.5–1 g/kg/day of amino acids, including reconstitution, dilution, infusion rate, and line flushing?
What is the recommended protocol for administering nephrosteril (amino acids) IV drip to a patient with impaired renal function?
Can an antacid tablet containing aluminum hydroxide, magnesium hydroxide, and simethicone be taken immediately after drinking milk, or should it be delayed?
In a patient with an acute ischemic stroke of unknown onset, what diagnostic imaging and acute management—including intravenous alteplase (tissue plasminogen activator) and endovascular thrombectomy—should be performed?
What is the appropriate empirical antibiotic regimen for a neonate with sepsis and suspected meningitis?
How should insulin glargine be combined with vildagliptin in a patient with type 2 diabetes who requires basal insulin but still has post‑prandial glucose excursions?
Can NSS (normal saline) be used as maintenance fluid in a 13‑day‑old infant?
Does abiraterone cause renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.